insights_auto
Why is EDIT down 2,71%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
2,51 US$
arrow_downward
-2,71%(-0,070) 1D
2,50 US$
arrow_downward
-0,40% (-0,0100)bedtimeAfter hours
Closed: 21 ოქტ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,59 US$
High
2,60 US$
Low
2,50 US$
Mkt. cap
385,49 მლნ.
Avg. vol.
3,03 მლნ.
Volume
1,14 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,74 US$
Beta
2,00
Shares outstanding
153,58 მლნ.
No. of employees
87
Open
2,59 US$
High
2,60 US$
Low
2,50 US$
Mkt. cap
385,49 მლნ.
Avg. vol.
3,03 მლნ.
Volume
1,14 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,74 US$
Beta
2,00
Shares outstanding
153,58 მლნ.
No. of employees
87
News stories
From web sources and news partners
Simply Wall Street
·
3 წუთის წინ
Amkor Technology (AMKR) Expands South Korea Capacity For AI Chip Packaging
Moomoo
·
34 წუთის წინ
Dow Jones Top Markets Headlines at 9 PM ET: SpaceX, Anthropic and Nvidia Help Snap Tech Stocks Out of Their Recent Malaise | Canada ...
MarketBeat
·
14 წუთის წინ
IperionX (NASDAQ:IPX) Sets New 52-Week Low - Should You Sell?
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc